HEALTH OF WOMAN.2017.1(117):145–157

Published: Green-top Guideline No. 52 December 2016
http://onlinelibrary.wiley.com/doi/10.1111/1471-0528.14178/epdf
Translation and adaptation: Shurpyak S. A.

REFERENCES
1. Scottish Obstetric Guidelines and Audit Project. The Management of Postpartum Haemorrhage: A Clinical Practice Guideline for Professionals involved in Maternity Care in Scotland. Pilot edition. Glasgow: SOGAP, 1998. http://healthcareimprovementscotland. org/his/idoc.ashx?docid=84ee51e6-d441-4dba-8ebf-4fa6a2857e0d& version=-1. Accessed 2015 Jul 2.

2. Mousa HA, Blum J, Abou El Senoun G, Shakur H, Alfirevic Z. 2014. Treatment for primary postpartum haemorrhage. Cochrane Database Syst Rev (2):CD003249. https://doi.org/10.1002/14651858.cd003249.pub3

3. Knight M, Tuffnell D, Kenyon S, Shakespeare J, Gray R, Kurinczuk JJ, editors on behalf of MBRRACE-UK. 2015. Saving Lives, Improving Mothers’ Care – Surveillance of maternal deaths in the UK 2011-13 and lessons learned to inform maternity care from the UK and Ireland Confidential Enquiries into Maternal Deaths and Morbidity 2009–13. Oxford: National Perinatal Epidemiology Unit, University of Oxford.

4. Alexander J, Thomas PW, Sanghera J. 2002. Treatments for secondary postpartum haemorrhage. Cochrane Database Syst Rev (1):CD002867. https://doi.org/10.1002/14651858.cd002867

5. Demers C, Derzko C, David M, Douglas J. 2005. Society of Obstetricians and Gynaecologists of Canada. Gynae-cological and obstetric management of women with inherited bleeding disorders. SOGC Clinical Practice Guidelines No 163. J Obstet Gynaecol Can 27:707–18. https://doi.org/10.1016/S1701-2163(16)30551-5

6. Baudo F, de Cataldo F. 2003. Italian Association of Haemophilia Centres (AICE): Register of acquired factor VIII inhibitors (RIIA). Acquired factor VIII inhibitors in pregnancy: data from the Italian Haemophilia Register relevant to clinical practice. BJOG 110:311–4. https://doi.org/10.1016/S1470-0328(03)01935-9; https://doi.org/10.1046/j.1471-0528.2003.01535.x; PMid:12628274

7. The Royal College of Surgeons of England. Code of Practice for the Surgical Management of Jehovah’s Witnesses. London: The Royal College of Surgeons of England. 2002.

8. The Association of Anaesthetists of Great Britain and Ireland. Management of Anaesthesia for Jehovah’s Witnesses, 2nd ed. London: AAGBI. 2005.

9. National Institute for Health and Care Excellence. Intrapartum care: care of healthy women and their babies during childbirth. NICE clinical guideline 190. Manchester: NICE. 2014.

10. Centre for Maternal and Child Enquiries (CMACE). Saving Mothers’ Lives: reviewing maternal deaths to make motherhood safer: 2006–08. The Eighth Report on Confidential Enquiries into Maternal Deaths in the United Kingdom. BJOG 2011;118 Suppl 1:1–203.

11. Royal College of Obstetricians and Gynaecologists. Antepartum Haemorrhage. Green-top Guideline No. 63. London: RCOG. 2011.

12. Royal College of Obstetricians and Gynaecologists. Placenta Praevia, Placenta Praevia Accreta and Vasa Praevia: Diagnosis and Management. Green-top Guideline 27. London: RCOG. 2011.

13. Royal College of Obstetricians and Gynaecologists. Blood Transfusion in Obstetrics. Green-top Guideline No. 47. London, RCOG. 2015.

14. Calvert C, Thomas SL, Ronsmans C, Wagner KS, Adler AJ, Filippi V. 2012. Identifying regional variation in the prevalence of postpartum haemorrhage: a systematic review and meta-analysis. PLoS ONE 7:e41114. https://doi.org/10.1371/journal.pone.0041114: PMid:22844432 PMCid:PMC3402540

15. Bryant A, Mhyre JM, Leffert LR, Hoban RA, Yakoob MY, Bateman BT. 2012. The association of maternal race and ethnicity and the risk of postpartum hemorrhage. Anesth Analg 115:1127–36. https://doi.org/10.1213/ANE.0b013e3182691e62; PMid:22886840

16. Combs CA, Murphy EL, Laros RK Jr. 1991. Factors associated with postpartum hemorrhage with vaginal birth. Obstet Gynecol 77:69–76. PMid:1984230

17. Stones RW, Paterson CM, Saunders NJ. 1993. Risk factors for major obstetric haemorrhage. Eur J Obstet Gynecol Reprod Biol 48:15–8. https://doi.org/10.1016/0028-2243(93)90047-G

18. Al-Zirqi I, Vangen S, Forsen L, Stray-Pedersen B. 2008. Prevalence and risk factors of severe obstetric haemorrhage. BJOG 115:1265–72. https://doi.org/10.1111/j.1471-0528.2008.01859.x; PMid:18715412

19. Tsu VD. 1993. Postpartum haemorrhage in Zimbabwe: a risk factor analysis. Br J Obstet Gynaecol 100:327–33. https://doi.org/10.1111/j.1471-0528.1993.tb12974.x; PMid:8494833

20. Bais JM, Eskes M, Pel M, Bonsel GJ, Bleker OP. 2004. Postpartum haemorrhage in nulliparous women: incidence and risk factors in low and high risk women. A Dutch population-based cohort study on standard (≥500 ml) and severe (≥1000 ml) postpartum haemorrhage. Eur J Obstet Gynecol Reprod Biol 115:166–72. https://doi.org/10.1016/j.ejogrb.2003.12.008

21. Magann EF, Evans S, Hutchinson M, Collins R, Howard BC, Morrison JC. 2005. Postpartum hemorrhage after vaginal birth: an analysis of risk factors. South Med J 98:419–22. https://doi.org/10.1097/01.SMJ.0000152760.34443.86; https://doi.org/10.1097/01.SMJ.0000163309.53317.B8

22. Magann EF, Evans S, Chauhan SP, Lanneau G, Fisk AD, Morrison JC. 2005. The length of the third stage of labor and the risk of postpartum hemorrhage. Obstet Gynecol 105:290–3. https://doi.org/10.1097/01.AOG.0000151993.83276.70; PMid:15684154

23. Sheiner E, Sarid L, Levy A, Seidman DS, Hallak M. 2005. Obstetric risk factors and outcome of pregnancies complicated with early postpartum hemorrhage: a population-based study. J Matern Fetal Neonatal Med 18:149–54. https://doi.org/10.1080/14767050500170088; PMid:16272036

24. Sosa CG, Althabe F, Beliz an JM, Buekens P. 2009. Risk factors for postpartum hemorrhage in vaginal deliveries in a Latin-American population. Obstet Gynecol 113:1313–9. https://doi.org/10.1097/AOG.0b013e3181a66b05; PMid:19461428 PMCid:PMC2730945

25. Brinsden PR, Clark AD. 1978. Postpartum haemorrhage after induced and spontaneous labour. Br Med J ii:855–6. https://doi.org/10.1136/bmj.2.6141.855

26. Selo-Ojeme DO, Okonofua FE. 1997. Risk factors for primary postpartum haemorrhage. A case control study. Arch Gynecol Obstet 259:179–87. https://doi.org/10.1007/BF02505330; PMid:9271837

27. World Health Organization. WHO recommendations for the prevention and treatment of postpartum haemorrhage. Geneva, WHO. 2012.

28. Oyelese Y, Ananth CV. 2010. Postpartum hemorrhage: epidemiology, risk factors, and causes. Clin Obstet Gynecol 53:147–56. https://doi.org/10.1097/GRF.0b013e3181cc406d; PMid:20142652

29. Confidential Enquiry into Maternal and Child Health. Why Mothers Die 2000–2002. The Sixth Report of the Confidential Enquiries into Maternal Deaths in the United Kingdom. London: RCOG Press. 2004.

30. Leduc D, Senikas V, Lalonde AB, Ballerman C, Biringer A, Delaney M et al. 2009. Clinical Practice Obstetrics Committee; Society of Obstetricians and Gynaecologists of Canada. Active management of the third stage of labour: prevention and treatment of postpartum hemorrhage. SOGC Clinical Practice Guideline No. 235. J Obstet Gynaecol Can 31:980–93. https://doi.org/10.1016/S1701-2163(16)34329-8

31. Combs CA, Murphy EL, Laros RK Jr. 1991. Factors associated with hemorrhage in cesarean deliveries. Obstet Gynecol 77:77–82. https://doi.org/10.1097/00006254-199106000-00011

32. National Institute for Health and Care Excellence. Antenatal Care. NICE clinical guideline 62. Manchester, NICE. 2008.

33. Pavord S, Myers B, Robinson S, Allard S, Strong J, Oppenheimer C. 2012. British Committee for Standards in Haematology. UK guidelines on the management of iron deficiency in pregnancy. Br J Haematol 156:588–600. https://doi.org/10.1111/j.1365-2141.2011.09012.x; PMid:22512001

34. Kavle JA, Stoltzfus RJ, Witter F, Tielsch JM, Khalfan SS, Caulfield LE. 2008. Association between anaemia during pregnancy and blood loss at and after delivery among women with vaginal births in Pemba Island, Zanzibar, Tanzania. J Health Popul Nutr 26:232–40. PMid:18686556 PMCid:PMC2740668

35. Hofmeyr GJ, Abdel-Aleem H, Abdel-Aleem MA. 2013. Uterine massage for preventing postpartum haemorrhage. Cochrane Database Syst Rev (7):CD006431. https://doi.org/10.1002/14651858.cd006431.pub3

36. McDonald SJ, Abbott JM, Higgins SP. 2004. Prophylactic ergometrine– oxytocin versus oxytocin for the third stage of labour. Cochrane Database Syst Rev (1):CD000201. https://doi.org/10.1002/14651858.cd000201.pub2

37. Tunçalp O, Hofmeyr GJ, Gülmezoglu AM. 2012. Prostaglandins for preventing postpartum haemorrhage. Cochrane Database Syst Rev (8):CD000494. https://doi.org/10.1002/14651858.cd000494.pub4

38. Oladapo OT, Fawole B, Blum J, Abalos E. 2012. Advance misoprostol distribution for preventing and treating postpartum haemorrhage. Cochrane Database Syst Rev (2):CD009336. https://doi.org/10.1002/14651858.cd009336.pub2

39. Begley CM, Gyte GM, Devane D, McGuire W, Weeks A. 2011. Active versus expectant management for women in the third stage of labour. Cochrane Database Syst Rev (11):CD007412. https://doi.org/10.1002/14651858.cd007412.pub3

40. Hutton EK, Hassan ES. 2007. Late vs early clamping of the umbilical cord in full-term neonates: systematic review and meta-analysis of controlled trials. JAMA 297:1241–52. https://doi.org/10.1001/jama.297.11.1241; PMid:17374818

41. Royal College of Obstetricians and Gynaecologists. Clamping of the Umbilical Cord and Placental Transfusion. Scientific Impact Paper No. 14. London, RCOG. 2015.

42. Tita AT, Szychowski JM, Rouse DJ, Bean CM, Chapman V, Nothern A et al. 2012. Higher-dose oxytocin and hemorrhage after vaginal delivery: a randomized controlled trial. Obstet Gynecol 119:293–300. https://doi.org/10.1097/AOG.0b013e318242da74; PMid:22227638 PMCid:PMC3282278

43. Gizzo S, Patrelli TS, Di Gangi S, Carrozzini M, Saccardi C, Zambon A et al. 2013. Which uterotonic is better to prevent the postpartum hemorrhage? Latest news in terms of clinical efficacy, side effects, and contraindications: a systematic review. Reprod Sci 20:1011–9. https://doi.org/10.1177/1933719112468951; PMid:23296037

44. Su LL, Chong YS, Samuel M. 2012. Carbetocin for preventing postpartum haemorrhage. Cochrane Database Syst Rev (4):CD005457. https://doi.org/10.1002/14651858.cd005457.pub3

45. Dennehy KC, Rosaeg OP, Cicutti NJ, Krepski B, Sylvain JP. 1998. Oxytocin injection after caesarean delivery: intravenous or intramyometrial? Can J Anaesth 45:635–9. https://doi.org/10.1007/BF03012092; PMid:9717594

46. Munn MB, Owen J, Vincent R, Wakefield M, Chestnut DH, Hauth JC. 2001. Comparison of two oxytocin regimens to prevent uterine atony at caesarean delivery: a randomized controlled trial. Obstet Gynecol 98:386–90. https://doi.org/10.1016/S0029-7844(01)01479-X; https://doi.org/10.1097/00006250-200109000-00005; PMid:11530117

47. Lokugamage AU, Paine M, Bassaw-Balroop K, Sullivan KR, El Refaey H, Rodeck CH. 2001. Active management of the third stage at caesarean section: a randomised controlled trial of misoprostol versus Syntocinon. Aust N Z J Obstet Gynaecol 41:411–4. https://doi.org/10.1111/j.1479-828X.2001.tb01319.x; PMid:11787915

48. Chou MM, MacKenzie IZ. 1994. A prospective, double-blind, randomized comparison of prophylactic intramyometrial 15-methyl prostaglandin F2a, 125 micrograms, and intravenous oxytocin, 20 units, for the control of blood loss at elective cesarean section. Am J Obstet Gynecol 171:1356–60. https://doi.org/10.1016/0002-9378(94)90160-0

49. Boucher M, Horbay GL, Griffin P, Deschamps Y, Desjardins C, Schulz M et al. 1998. Double-blind, randomized comparison of the effect of carbetocin and oxytocin on intraoperative blood loss and uterine tone of patients undergoing cesarean section. J Perinatol 18:202–7. PMid:9659650

50. Dansereau J, Joshi AK, Helewa ME, Doran TA, Lange IR, Luther ER et al. 1999. Double-blind comparison of carbetocin versus oxytocin in prevention of uterine atony after cesarean section. Am J Obstet Gynecol 180:670–6. https://doi.org/10.1016/S0002-9378(99)70271-1

51. National Collaborating Centre for Women’s and Children’s Health. Caesarean Section. London, RCOG. 2011.

52. Novikova N, Hofmeyr GJ, Cluver C. 2015. Tranexamic acid for preventing postpartum haemorrhage. Cochrane Database Syst Rev (6):CD007872. https://doi.org/10.1002/14651858.cd007872.pub3

53. Glover P. 2003. Blood loss at delivery: how accurate is your estimation? Aust J Midwifery 16:21–4. https://doi.org/10.1016/S1031-170X(03)80005-3

54. Toledo P, McCarthy RJ, Hewlett BJ, Fitzgerald PC, Wong CA. 2007. The accuracy of blood loss estimation after simulated vaginal delivery. Anesth Analg 105:1736–40. https://doi.org/10.1213/01.ane.0000286233.48111.d8; PMid:18042876

55. Patel A, Goudar SS, Geller SE, Kodkany BS, Edlavitch SA, Wagh K et al. 2006. Drape estimation vs. visual assessment for estimating postpartum hemorrhage. Int J Gynaecol Obstet 93:220–4. https://doi.org/10.1016/j.ijgo.2006.02.014; PMid:16626718

56. Schorn MN. 2010. Measurement of blood loss: review of the literature. J Midwifery Womens Health 55:20–7. https://doi.org/10.1016/j.jmwh.2009.02.014; PMid:20129226

57. Zhang WH, Deneux-Tharaux C, Brocklehurst P, Juszczak E, Joslin M, Alexander S. 2010. EUPHRATES Group. Effect of a collector bag for measurement of postpartum blood loss after vaginal delivery: cluster randomised trial in 13 European countries. BMJ 340:c293. https://doi.org/10.1136/bmj.c293; PMid:20123835 PMCid:PMC2815270

58. Buckland SS, Homer CS. 2007. Estimating blood loss after birth: using simulated clinical examples. Women Birth 20:85–8. https://doi.org/10.1016/j.wombi.2007.01.001; PMid:17320496

59. Bose P, Regan F, Paterson-Brown S. 2006. Improving the accuracy of estimated blood loss at obstetric haemorrhage using clinical reconstructions. BJOG 113:919–24. https://doi.org/10.1111/j.1471-0528.2006.01018.x; PMid:16907938

60. Rath WH. 2011. Postpartum hemorrhage – update on problems of definitions and diagnosis. Acta Obstet Gynecol Scand 90:421–8. https://doi.org/10.1111/j.1600-0412.2011.01107.x; PMid:21332452

61. Allgöwer M, Burri C. 1967. «Shock index». Dtsch Med Wochenschr 92:1947–50. German. https://doi.org/10.1055/s-0028-1106070; PMid:5299769

62. Nathan HL, El Ayadi A, Hezelgrave NL, Seed P, Butrick E, Miller S et al. 2015. Shock index: an effective predictor of outcome in postpartum haemorrhage? BJOG 122:268–75. https://doi.org/10.1111/1471-0528.13206; PMid:25546050

63. Royal College of Obstetricians and Gynaecologists. Responsibility of Consultant On-Call. Good Practice No. 8. London, RCOG. 2009.

64. Duthie SJ, Ven D, Yung GL, Guang DZ, Chan SY, Ma HK. 1991. Discrepancy between laboratory determination and visual estimation of blood loss during normal delivery. Eur J Obstet Gynecol Reprod Biol 38:119–24. https://doi.org/10.1016/0028-2243(91)90188-Q

65. Ho AM, Karmakar MK, Dion PW. 2005. Are we giving enough coagulation factors during major trauma resuscitation? Am J Surg 190:479–84. https://doi.org/10.1016/j.amjsurg.2005.03.034; PMid:16105540

66. Hirshberg A, Dugas M, Banez EI, Scott BG, Wall MJ Jr, Mattox KL. 2003. Minimizing dilutional coagulopathy in exsanguinating hemorrhage: a computer simulation. J Trauma 54:454–63. https://doi.org/10.1097/01.TA.0000053245.08642.1F; PMid:12634523

67. Hunt BJ, Allard S, Keeling D, Norfolk D, Stanworth SJ, Pendry K. 2015. British Committee for Standards in Haematology. A practical guideline for the haematological management of major haemorrhage. Br J Haematol 170:788–803. https://doi.org/10.1111/bjh.13580; PMid:26147359

68. British Committee for Standards in Haematology, Stainsby D, MacLennan S, Thomas D, Isaac J, Hamilton PJ. 2006. Guidelines on the management of massive blood loss. Br J Haematol 135:634–41. https://doi.org/10.1111/j.1365-2141.2006.06355.x; PMid:17107347

69. Cochrane Injuries Group Albumin Reviewers. Human albumin administration in critically ill patients: systematic review of randomised controlled trials. BMJ 1998. 317:235–40. https://doi.org/10.1136/bmj.317.7153.235; PMid:9677209 PMCid:PMC28613

70. Schierhout G, Roberts I. 1998. Fluid resuscitation with colloid or crystalloid solutions in critically ill patients: a systematic review of randomised trials. BMJ 316:961–4. https://doi.org/10.1136/bmj.316.7136.961; PMid:9550953 PMCid:PMC28497

71. Association of Anaesthetists of Great Britain and Ireland, Thomas D, Wee M, Clyburn P, Walker I, Brohi K et al. 2010. Blood transfusion and the anaesthetist: management of massive haemorrhage. Anaesthesia 65:1153–61. https://doi.org/10.1111/j.1365-2044.2010.06538.x; PMCid:PMC3032944

72. Luna GK, Maier RV, Pavlin EG, Anardi D, Copass MK, Oreskovich MR. 1987. Incidence and effect of hypothermia in seriously injured patients. J Trauma 27:1014–8. https://doi.org/10.1097/00005373-198709000-00010; PMid:3656463

73. World Health Organization. WHO guidelines for the management of postpartum haemorrhage and retained placenta. Geneva: WHO; 2009. http: //apps.who.int/iris/bitstream/ 10665/ 44171/1/978924159– 8514_eng.pdf. Accessed 2016 Feb 4.  

74. Perel P, Roberts I, Ker K. 2013. Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev (2):CD000567. https://doi.org/10.1002/14651858.cd000567.pub6

75. Murphy MF, Wallington TB, Kelsey P, Boulton F, Bruce M, Cohen H et al. 2001. British Committee for Standards in Haematology, Blood Transfusion Task Force. Guidelines for the clinical use of red cell transfusions. Br J Haematol 113:24–31. https://doi.org/10.1046/j.1365-2141.2001.02701.x; PMid:11328275

76. United Kingdom Blood Services; Norfolk D, editor. Handbook of Transfusion Medicine. 5th ed. Norwich, TSO. 2013.

77. Serious Hazards of Transfusion (SHOT). www.shotuk.org/. Accessed 2013 Aug 6.

78. Kozek-Langenecker SA, Afshari A, Albaladejo P, Santullano CA, De Robertis E, Filipescu DC et al. 2013. Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology. Eur J Anaesthesiol 30:270–382. https://doi.org/10.1097/EJA.0b013e32835f4d5b; PMid:23656742

79. British Committee for Standards in Haematology, Milkins C, Berryman J, Cantwell C, Elliott C, Haggas R et al. 2013. Guidelines for pre-transfusion compatibility procedures in blood transfusion laboratories. Transfus Med 23:3–35. https://doi.org/10.1111/j.1365-3148.2012.01199.x; PMid:23216974

80. Royal College of Obstetricians and Gynaecologists. The Management of Women with Red Cell Antibodies during Pregnancy. Green-top Guideline No. 65. London, RCOG. 2014.

81. Laupacis A, Brown J, Costello B, Delage G, Freedman J, Hume H et al. 2001. Prevention of posttransfusion CMV in the era of universal WBC reduction: a consensus statement. Transfusion 41:560–9. https://doi.org/10.1046/j.1537-2995.2001.41040560.x; PMid:11316911

82. Advisory Committee on the Safety of Blood, Tissues and Organs. Cytomegalovirus tested blood components – position statement. London, Department of Health. 2012.

83. Carless PA, Henry DA, Moxey AJ, O’Connell D, Brown T, Fergusson DA. 2010. Cell salvage for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev (4):CD001888. https://doi.org/10.1002/14651858.cd001888.pub3

84. Catling SJ, Williams S, Fielding AM. 1999. Cell salvage in obstetrics: an evaluation of the ability of cell salvage combined with leucocyte depletion filtration to remove amniotic fluid from operative blood loss at caesarean section. Int J Obstet Anesth 8:79–84. https://doi.org/10.1016/S0959-289X(99)80002-8

85. National Institute for Health and Clinical Excellence. Intraoperative blood cell salvage in obstetrics. NICE interventional procedure guidance 144. Manchester, NICE. 2005.

86. Wee MY, Thomas D, Verma R, Jones J, Catling S, Isaac J et al. 2009. The Association of Anaesthetists of Great Britain and Ireland. Blood Transfusion and the Anaesthetist: Intra-operative Cell Salvage. AAGBI Safety Guideline. London: AAGBI.

87. Liumbruno GM, Liumbruno C, Rafanelli D. 2011. Intraoperative cell salvage in obstetrics: is it a real therapeutic option? Transfusion 51:2244–56. https://doi.org/10.1111/j.1537-2995.2011.03116.x; PMid:21446940

88. Geoghegan J, Middleton L, Moore P, Subseson G, Khan K, Daniels J. 2015. Routine cell salvage during elective caesarean section: a pilot randomised trial. Int J Obstet Anesth 24:86–7. https://doi.org/10.1016/j.ijoa.2014.08.003; PMid:25499013

89. Solomon C, Collis RE, Collins PW. 2012. Haemostatic monitoring during postpartum haemorrhage and implications for management. Br J Anaesth 109:851–63. https://doi.org/10.1093/bja/aes361; PMid:23075633 PMCid:PMC3498756

90. Avidan MS, Alcock EL, Da Fonseca J, Ponte J, Desai JB, Despotis GJ et al. 2004. Comparison of structured use of routine laboratory tests or near-patient assessment with clinical judgement in the management of bleeding after cardiac surgery. Br J Anaesth 92:178–86. https://doi.org/10.1093/bja/aeh037; PMid:14722166

91. Allard S, Green L, Hunt BJ. 2014. How we manage the haematological aspects of major obstetric haemorrhage. Br J Haematol 164:177–88. https://doi.org/10.1111/bjh.12605; PMid:24383841

92. Bell SF, Rayment R, Collins PW, Collis RE. 2010. The use of fibrinogen concentrate to correct hypofibrinogenaemia rapidly during obstetric haemorrhage. Int J Obstet Anesth 19:218–23. https://doi.org/10.1016/j.ijoa.2009.08.004; PMid:20194010

93. Collis RE, Collins PW. 2015. Haemostatic management of obstetric haemorrhage. Anaesthesia 70 Suppl 1:78–86, e27–8.

94. Mallaiah S, Barclay P, Harrod I, Chevannes C, Bhalla A. 2015. Introduction of an algorithm for ROTEM-guided fibrinogen concentrate administration in major obstetric haemorrhage. Anaesthesia 70:166–75. https://doi.org/10.1111/anae.12859; PMid:25289791

95. Plaat F, Bogod D, Bythell V, Mushambi M, Clyburn P, Lucas N et al. 2013. Association of Anaesthetists of Great Britain & Ireland; Obstetric Anaesthetists’ Association. OAA / AAGBI Guidelines for Obstetric Anaesthetic Services 2013. London, AAGBI.

96. National Institute for Health and Care Excellence. Detecting, managing and monitoring haemostasis: viscoelastometric point of care testing (ROTEM, TEG and Sonoclot systems). NICE diagnostics guidance 13. Manchester, NICE. 2014.

97. Charbit B, Mandelbrot L, Samain E, Baron G, Haddaoui B, Keita H et al. 2007. PPH Study Group. The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage. J Thromb Haemost 5:266–73. https://doi.org/10.1111/j.1538-7836.2007.02297.x; PMid:17087729

98. Collins PW, Lilley G, Bruynseels D, Laurent DB, Cannings-John R, Precious E et al. 2014. Fibrin-based clot formation as an early and rapid biomarker for progression of postpartum hemorrhage: a prospective study. Blood 124:1727–36. https://doi.org/10.1182/blood-2014-04-567891; PMid:25024304

99. de Lloyd L, Bovington R, Kaye A, Collis RE, Rayment R, Sanders J et al. 2011. Standard haemostatic tests following major obstetric haemorrhage. Int J Obstet Anesth 20:135–41. https://doi.org/10.1016/j.ijoa.2010.12.002; PMid:21439811

100. Li G, Rachmale S, Kojicic M, Shahjehan K, Malinchoc M, Kor DJ et al. 2011. Incidence and transfusion risk factors for transfusion-associated circulatory overload among medical intensive care unit patients. Transfusion 51:338–43. https://doi.org/10.1111/j.1537-2995.2010.02816.x; PMid:20723173 PMCid:PMC3006039

101. Teofili L, Bianchi M, Zanfini BA, Catarci S, Sicuranza R, Spartano S et al. 2014. Acute lung injury complicating blood transfusion in post-partum hemorrhage: incidence and risk factors. Mediterr J Hematol Infect Dis 6:e2014.069.

102. Collins PW, Solomon C, Sutor K, Crispin D, Hochleitner G, Rizoli S et al. 2014. Theoretical modelling of fibrinogen supplementation with therapeutic plasma, cryoprecipitate, or fibrinogen concentrate. Br J Anaesth 113:585–95. https://doi.org/10.1093/bja/aeu086; PMid:25064078 PMCid:PMC4166889

103. Hiippala ST, Myllyl€a GJ, Vahtera EM. 1995. Hemostatic factors and replacement of major blood loss with plasma-poor red cell concentrates. Anesth Analg 81:360–5. https://doi.org/10.1213/00000539-199508000-00026; https://doi.org/10.1097/00000539-199508000-00026; PMid:7542432

104. Chowdary P, Saayman AG, Paulus U, Findlay GP, Collins PW. 2004. Efficacy of standard dose and 30 ml/kg fresh frozen plasma in correcting laboratory parameters of haemostasis in critically ill patients. Br J Haematol 125:69–73. https://doi.org/10.1111/j.1365-2141.2004.04868.x; PMid:15015971

105. Duguid J, O’Shaughnessy DF, Atterbury C, Bolton Maggs P, Murphy M, Thomas D et al. 2004. British Committee for Standards in Haematology, Blood Transfusion Task Force. Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant. Br J Haematol 126:11–28. https://doi.org/10.1111/j.1365-2141.2004.04972.x; PMid:15198728

106. Tikkanen M. 2011. Placental abruption: epidemiology, risk factors and consequences. Acta Obstet Gynecol Scand 90:140–9. https://doi.org/10.1111/j.1600-0412.2010.01030.x; PMid:21241259

107. Levi M. 2013. Pathogenesis and management of peripartum coagulopathic calamities (disseminated intravascular coagulation and amniotic fluid embolism). Thromb Res 131 Suppl 1:S32–4. https://doi.org/10.1016/S0049-3848(13)70017-3

108. Green L, Knight M, Seeney F, Hopkinson C, Collins PW, Collis RE et al. 2016. The haematological features and transfusion management of women who required massive transfusion for major obstetric haemorrhage in the UK: a population based study. Br J Haematol 172:616–24. https://doi.org/10.1111/bjh.13864; PMid:26683982

109. Cortet M, Deneux-Tharaux C, Dupont C, Colin C, Rudigoz RC, Bouvier-Colle MH et al. 2012. Association between fibrinogen level and severity of postpartum haemorrhage: secondary analysis of a prospective trial. Br J Anaesth 108:984–9. https://doi.org/10.1093/bja/aes096; PMid:22490316

110. De Lloyd L, Collins PW, Kaye A, Collis RE. 2012. Early fibrinogen as a predictor of red cell requirements during postpartum haemorrhage. Int J Obstet Anesth 21 Suppl 1:S13.

111. Gayat E, Resche-Rigon M, Morel O, Rossignol M, Mantz J, Nicolas-Robin A et al. 2011. Predictive factors of advanced interventional procedures in a multicentre severe postpartum haemorrhage study. Intensive Care Med 37:1816–25. https://doi.org/10.1007/s00134-011-2315-0; PMid:21805157

112. Wikkelsш AJ, Edwards HM, Afshari A, Stensballe J, Langhoff-Roos J, Albrechtsen C et al. 2015. FIB-PPH trial group. Pre-emptive treatment with fibrinogen concentrate for postpartum haemorrhage: randomized controlled trial. Br J Anaesth 114:623–33. https://doi.org/10.1093/bja/aeu444; PMid:25586727

113. Ahmed S, Harrity C, Johnson S, Varadkar S, McMorrow S, Fanning R et al. 2012. The efficacy of fibrinogen concentrate compared with cryoprecipitate in major obstetric haemorrhage – an observational study. Transfus Med 22:344–9. https://doi.org/10.1111/j.1365-3148.2012.01178.x; PMid:22994449

114. Gollop ND, Chilcott J, Benton A, Rayment R, Jones J, Collins PW. 2012. National audit of the use of fibrinogen concentrate to correct hypofibrinogenaemia. Transfus Med 22:350–5. https://doi.org/10.1111/j.1365-3148.2012.01168.x; PMid:22697297

115. Mallaiah S, Chevannes C, McNamara H, Barclay P. 2015. A reply. Anaesthesia 70:760–1. https://doi.org/10.1111/anae.13272; https://doi.org/10.1111/anae.13128; PMid:25959192

116. Glover NJ, Collis RE, Collins P. 2010. Fibrinogen concentrate use during major obstetric haemorrhage. Anaesthesia 65:1229–30. https://doi.org/10.1111/j.1365-2044.2010.06548.x; PMid:21182609

117. Weinkove R, Rangarajan S. 2008. Fibrinogen concentrate for acquired hypofibrinogenaemic states. Transfus Med 18:151–7. https://doi.org/10.1111/j.1365-3148.2008.00854.x; PMid:18598277

118. CRASH-2 collaborators, Roberts I, Shakur H, Afolabi A, Brohi K, Coats T et al. 2011. The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. Lancet 377:1096–101, 1101. e1–2.

119. Ducloy-Bouthors AS, Jude B, Duhamel A, Broisin F, Huissoud C, Keita-Meyer H et al. 2011. The EXADELI Study Group. High-dose tranexamic acid reduces blood loss in postpartum haemorrhage. Crit Care 15:R117. https://doi.org/10.1186/cc10143; PMid:21496253 PMCid:PMC3219400

120. Shakur H, Elbourne D, G€ulmezoglu M, Alfirevic Z, Ronsmans C, Allen E et al. 2010. The WOMAN Trial (World Maternal Antifibrinolytic Trial): tranexamic acid for the treatment of postpartum haemorrhage: an international randomised, double blind placebo controlled trial. Trials 11:40. https://doi.org/10.1186/1745-6215-11-40; PMid:20398351 PMCid:PMC2864262

121. Ahonen J. 2012. The role of recombinant activated factor VII in obstetric hemorrhage. Curr Opin Anaesthesiol 25:309–14. https://doi.org/10.1097/ACO.0b013e3283532007; PMid:22473215

122. Alfirevic Z, Elbourne D, Pavord S, Bolte A, Van Geijn H, Mercier F et al. 2007. Use of recombinant activated factor VII in primary postpartum hemorrhage: the Northern European Registry 2000–2004. Obstet Gynecol 110:1270–8. https://doi.org/10.1097/01.AOG.0000288515.48066.99; PMid:18055720

123. Franchini M, Franchi M, Bergamini V, Salvagno GL, Montagnana M, Lippi G. 2008. A critical review on the use of recombinant factor VIIa in life-threatening obstetric postpartum hemorrhage. Semin Thromb Hemost 34:104–12. https://doi.org/10.1055/s-2008-1066022; PMid:18393147

124. Franchini M, Franchi M, Bergamini V, Montagnana M, Salvagno GL, Targher G et al. 2010. The use of recombinant activated FVII in postpartum hemorrhage. Clin Obstet Gynecol 53:219–27. https://doi.org/10.1097/GRF.0b013e3181cc4378; PMid:20142658

125. Lavigne-Lissalde G, Aya AG, Mercier FJ, Roger-Christoph S, Chauleur C, Morau E et al. 2015. Recombinant human FVIIa for reducing the need for invasive second-line therapies in severe refractory postpartum hemorrhage: a multicenter, randomized, open controlled trial. J Thromb Haemost 13:520–9. https://doi.org/10.1111/jth.12844; PMid:25594352

126. Levi M, Levy JH, Andersen HF, Truloff D. 2010. Safety of recombinant activated factor VII in randomized clinical trials. N Engl J Med 363:1791–800. https://doi.org/10.1056/NEJMoa1006221; PMid:21047223

127. de Groot AN. 1995. Prevention of postpartum haemorrhage. Baillieres Clin Obstet Gynaecol 9:619–31. https://doi.org/10.1016/S0950-3552(05)80385-2

128. Walker ID, Walker JJ, Colvin BT, Letsky EA, Rivers R, Stevens R. 1994. Haemostasis and Thrombosis Task Force. Investigation and management of haemorrhagic disorders in pregnancy. J Clin Pathol 47:100–8. https://doi.org/10.1136/jcp.47.2.100; PMid:8132822 PMCid:PMC501820

129. Patel N, editor. Maternal Mortality – the Way Forward. Some Implications of the Report on Confidential Enquiries into Maternal Deaths in the United Kingdom 1985-87. London: RCOG; 1992.

130. Franchini M, Lippi G, Franchi M. 2007. The use of recombinant activated factor VII in obstetric and gynaecological haemorrhage. BJOG 114:8–15. https://doi.org/10.1111/j.1471-0528.2006.01156.x; PMid:17233855

131. Confidential Enquiry into Maternal and Child Health. Saving Mothers’ Lives: Reviewing maternal deaths to make motherhood safer – 2003-2005. The Seventh Report of the Confidential Enquiries into Maternal Deaths in the United Kingdom. London, CEMACH. 2007.

132. Royal College of Obstetricians and Gynaecologists. Reducing the Risk of Venous Thromboembolism during Pregnancy and the Puerperium. Green-top Guideline 37a. London, RCOG. 2015.

133. Palmer SK. Anaesthesia care for obstetric patients in the United States. In: Reynolds F, editor. Regional Analgesia in Obstetrics: A Millennium Update. London, Springer-Verlag London. 2000: 3–10.  https://doi.org/10.1007/978-1-4471-0435-3_1

134. Rajan PV, Wing DA. 2010. Postpartum hemorrhage: evidence-based medical interventions for prevention and treatment. Clin Obstet Gynecol 53:165–81. https://doi.org/10.1097/GRF.0b013e3181ce0965; PMid:20142654

135. Joint Formulary Committee. British National Formulary, 69th ed. London, BMJ Group and Pharmaceutical Press. 2015.

136. Lewis G, editor. 2001. The National Institute for Clinical Excellence; The Scottish Executive Health Department; The Department of Health, Social Services and Public Safety: Northern Ireland. Why Mothers Die 1997–1999. The fifth report of the Confidential Enquiries into Maternal Deaths in the United Kingdom. London, RCOG Press.

137. Buttino L Jr, Garite TJ. 1986. The use of 15 methyl F2 alpha prostaglandin (Prostin 15M) for the control of postpartum hemorrhage. Am J Perinatol 3:241–3. https://doi.org/10.1055/s-2007-999875; PMid:3487334

138. Oleen MA, Mariano JP. 1990. Controlling refractory atonic postpartum hemorrhage with Hemabate sterile solution. Am J Obstet Gynecol 162:205–8. https://doi.org/10.1016/0002-9378(90)90851-W

139. Hofmeyr GJ, Walraven G, G€ulmezoglu AM, Maholwana B, Alfirevic Z, Villar J. 2005. Misoprostol to treat postpartum haemorrhage: a systematic review. BJOG 112:547–53. https://doi.org/10.1111/j.1471-0528.2004.00512.x; PMid:15842275

140. Meckstroth KR, Whitaker AK, Bertisch S, Goldberg AB, Darney PD. 2006. Misoprostol administered by epithelial routes. Drug absorption and uterine response. Obstet Gynecol 108:582–90. https://doi.org/10.1097/01.aog.0000230398.32794.9d

141. Tang J, Kapp N, Dragoman M, de Souza JP. 2013. WHO recommendations for misoprostol use for obstetric and gynecologic indications. Int J Gynaecol Obstet 121:186–9. https://doi.org/10.1016/j.ijgo.2012.12.009; PMid:23433680

142. International Federation of Gynecology and Obstetrics. Treatment of Post-Partum Haemorrhage with Misoprostol. FIGO Guideline Annotated Version. London, FIGO. 2012. www. k4health. org/toolkits/postpartumhemorrhage/treatment- post-partum-haemorrhage-misoprostol-figo-guideline-annotated. Accessed 2016 Feb 4.

143. Georgiou C. 2009. Balloon tamponade in the management of postpartum haemorrhage: a review. BJOG 116:748–57. https://doi.org/10.1111/j.1471-0528.2009.02113.x; PMid:19432563

144. Ikechebelu JI, Obi RA, Joe-Ikechebelu NN. 2005. The control of postpartum haemorrhage with intrauterine Foley catheter. J Obstet Gynaecol 25:70–2. https://doi.org/10.1080/01443610400025861; PMid:16147704

145. Bakri YN, Amri A, Abdul Jabbar F. 2001. Tamponade-balloon for obstetrical bleeding. Int J Gynaecol Obstet 74:139–42. https://doi.org/10.1016/S0020-7292(01)00395-2

146. Chan C, Razvi K, Tham KF, Arulkumaran S. 1997. The use of a Sengstaken-Blakemore tube to control post-partum hemorrhage. Int J Gynaecol Obstet 58:251–2. https://doi.org/10.1016/S0020-7292(97)00090-8

147. Condous GS, Arulkumaran S, Symonds I, Chapman R, Sinha A, Razvi K. 2003. The «tamponade test» in the management of massive postpartum hemorrhage. Obstet Gynecol 101:767–72. https://doi.org/10.1097/00006250-200304000-00026; https://doi.org/10.1016/S0029-7844(03)00046-2

148. Akhter S, Begum MR, Kabir Z, Rashid M, Laila TR, Zabeen F. 2003. Use of a condom to control massive postpartum hemorrhage. MedGenMed 5:38. PMid:14600674

149. Keriakos R, Mukhopadhyay A. 2006. The use of the Rusch balloon for management of severe postpartum haemorrhage. J Obstet Gynaecol 26:335–8. https://doi.org/10.1080/01443610600595077; PMid:16753685

150. Lennox C, Marr L. 2014. Reproductive Health Programme, Healthcare Impro-vement Scotland. Scottish Confi-dential Audit of Severe Maternal Morbidity: reducing avoidable harm. 10th Annual Report. Edinburgh: Healthcare Impro-vement Scotland.

151. Frenzel D, Condous GS, Papageorghiou AT, McWhinney NA. 2005. The use of the ‘tamponade test’ to stop massive obstetric haemorrhage in placenta accreta. BJOG 112:676–7. https://doi.org/10.1111/j.1471-0528.2005.00491.x; PMid:15842298

152. Tindell K, Garfinkel R, Abu-Haydar E, Ahn R, Burke TF, Conn K et al. 2013. Uterine balloon tamponade for the treatment of postpartum haemorrhage in resource-poor settings: a systematic review. BJOG 120:5–14. https://doi.org/10.1111/j.1471-0528.2012.03454.x; PMid:22882240

153. Matsubara S, Yano H, Ohkuchi A, Kuwata T, Usui R, Suzuki M. 2013. Uterine compression sutures for postpartum hemorrhage: an overview. Acta Obstet Gynecol Scand 92:378–85. https://doi.org/10.1111/aogs.12077; PMid:23330882

154. B-Lynch C, Coker A, Lawal AH, Abu J, Cowen MJ. 1997. The B-Lynch surgical technique for the control of massive postpartum haemorrhage: an alternative to hysterectomy Five cases reported. Br J Obstet Gynaecol 104:372–5. https://doi.org/10.1111/j.1471-0528.1997.tb11471.x; PMid:9091019

155. Harma M, Gungen N, Ozturk A. 2005. B-Lynch uterine compression suture for postpartum haemorrhage due to placenta praevia accreta. Aust N Z J Obstet Gynaecol 45:93–5. https://doi.org/10.1111/j.1479-828X.2005.00340.x; PMid:15730380

156. Hayman RG, Arulkumaran S, Steer PJ. 2002. Uterine compression sutures: surgical management of postpartum hemorrhage. Obstet Gynecol 99:502–6. https://doi.org/10.1097/00006250-200203000-00022; https://doi.org/10.1016/S0029-7844(01)01643-X

157. Ghezzi F, Cromi A, Uccella S, Raio L, Bolis P, Surbek D. 2007. The Hayman technique: a simple method to treat postpartum haemorrhage. BJOG 114:362–5. https://doi.org/10.1111/j.1471-0528.2006.01204.x; PMid:17217361

158. Hwu YM, Chen CP, Chen HS, Su TH. 2005. Parallel vertical compression sutures: a technique to control bleeding from placenta praevia or accreta during caesarean section. BJOG 112:1420–3. https://doi.org/10.1111/j.1471-0528.2005.00666.x; PMid:16167948

159. Kafali H, Demir N, Soylemez F, Yurtseven S. 2003. Hemostatic cervical suturing technique for management of uncontrollable postpartum haemorrhage originating from the cervical canal. Eur J Obstet Gynecol Reprod Biol 110:35–8. https://doi.org/10.1016/S0301-2115(03)00104-0

160. Makino S, Tanaka T, Yorifuji T, Koshiishi T, Sugimura M, Takeda S. 2012. Double vertical compression sutures: A novel conservative approach to managing post-partum haemorrhage due to placenta praevia and atonic bleeding. Aust N Z J Obstet Gynaecol 52:290–2. https://doi.org/10.1111/j.1479-828X.2012.01422.x; PMid:22413844

161. Аyem G, Kurinczuk JJ, Alfirevic Z, Spark P, Brocklehurst P, Knight M. 2011. U.K. Obstetric Surveillance System (UKOSS). Uterine compression sutures for the management of severe postpartum hemorrhage. Obstet Gynecol 117:14–20.

162. Fotopoulou C, Dudenhausen JW. 2010. Uterine compression sutures for preserving fertility in severe postpartum haemorrhage: an overview 13 years after the first description. J Obstet Gynaecol 30:339–49. https://doi.org/10.3109/01443611003650233; PMid:20455714

163. Diemert A, Ortmeyer G, Hollwitz B, Lotz M, Somville T, Glosemeyer P et al. 2012. The combination of intrauterine balloon tamponade and the B-Lynch procedure for the treatment of severe postpartum hemorrhage. Am J Obstet Gynecol 206:65.e1–4. https://doi.org/10.1016/j.ajog.2011.07.041; PMid:22000893

164. Yoong W, Ridout A, Memtsa M, Stavroulis A, Aref-Adib M, Ramsay-Marcelle Z et al. 2012. Application of uterine compression suture in association with intrauterine balloon tamponade (‘uterine sandwich’) for postpartum hemorrhage. Acta Obstet Gynecol Scand 91:147–51. https://doi.org/10.1111/j.1600-0412.2011.01153.x; PMid:21501126

165. Nelson WL, O’Brien JM. 2007. The uterine sandwich for persistent uterine atony: combining the B-Lynch compression suture and an intrauterine Bakri balloon. Am J Obstet Gynecol 196:e9–10. https://doi.org/10.1016/j.ajog.2006.10.887; PMid:17466689

166. AbdRabbo SA. 1994. Stepwise uterine devascularization: a novel technique for management of uncontrolled postpartum hemorrhage with preservation of the uterus. Am J Obstet Gynecol 171:694–700. https://doi.org/10.1016/0002-9378(94)90084-1

167. Sentilhes L, Gromez A, Descamps P, Marpeau L. 2009. Why stepwise uterine devascularization should be first-line conservative surgical treatment to control severe postpartum hemorrhage? Acta Obstet Gynecol Scand 88:490–2. https://doi.org/10.1080/00016340902792441

168. Joshi VM, Otiv SR, Majumder R, Nikam YA, Shrivastava M. 2007. Internal iliac artery ligation for arresting postpartum haemorrhage. BJOG 114:356–61. https://doi.org/10.1111/j.1471-0528.2006.01235.x; PMid:17261120

169. Nizard J, Barrinque L, Frydman R, Fernandez H. 2003. Fertility and pregnancy outcomes following hypogastric artery ligation for severe post-partum haemorrhage. Hum Reprod 18:844–8. https://doi.org/10.1093/humrep/deg161; PMid:12660282

170. Doumouchtsis SK, Nikolopoulos K, Talaulikar VS, Krishna A, Arulkumaran S. 2014. Menstrual and fertility outcomes following the surgical management of postpartum haemorrhage: a systematic review. BJOG 121:382–8. https://doi.org/10.1111/1471-0528.12546; PMid:24321038

171. Lee HY, Shin JH, Kim J, Yoon HK, Ko GY, Won HS et al. 2012. Primary postpartum hemorrhage: outcome of pelvic arterial embolization in 251 patients at a single institution. Radiology 264:903–9. https://doi.org/10.1148/radiol.12111383; PMid:22829685

172. Salomon LJ, de Tayrac R, Castaigne-Meary V, Audibert F, Musset D, Ciorascu R et al. 2003. Fertility and pregnancy outcome following pelvic arterial embolization for severe post-partum haemorrhage. A cohort study. Hum Reprod 18:849–52. https://doi.org/10.1093/humrep/deg168; PMid:12660283

173. Descargues G, Mauger Tinlot F, Douvrin F, Clavier E, Lemoine JP, Marpeau L. 2004. Menses, fertility and pregnancy after arterial embolization for the control of postpartum haemorrhage. Hum Reprod 19:339–43. https://doi.org/10.1093/humrep/deh082; PMid:14747177

174. Fargeaudou Y, Morel O, Soyer P, Gayat E, Sirol M, Boudiaf M et al. 2010. Persistent postpartum haemorrhage after failed arterial ligation: value of pelvic embolisation. Eur Radiol 20:1777–85. https://doi.org/10.1007/s00330-010-1713-y; PMid:20309561

175. Brace V, Kernaghan D, Penney G. 2007. Learning from adverse clinical outcomes: major obstetric haemorrhage in Scotland, 2003–05. BJOG 114:1388–96. https://doi.org/10.1111/j.1471-0528.2007.01533.x; PMid:17949379

176. Duffy S, Gaffney G. 2001. Maternal admissions to ICU – time to re– evaluate. Ir Med J 94:248–9. PMid:11758629

177. Neill A, Thornton S. 2002. Secondary postpartum haemorrhage. J Obstet Gynaecol 22:119–22. https://doi.org/10.1080/01443610120113238; PMid:12521690

178. Babarinsa IA, Hayman RG, Draycott TJ. 2011. Secondary post-partum haemorrhage: challenges in evidence-based causes and management. Eur J Obstet Gynecol Reprod Biol 159:255–60. https://doi.org/10.1016/j.ejogrb.2011.07.029; PMid:21839573

179. Rome RM. 1975. Secondary postpartum haemorrhage. Br J Obstet Gynaecol 82:289–92. https://doi.org/10.1111/j.1471-0528.1975.tb00636.x; PMid:1079136

180. Pather S, Ford M, Reid R, Sykes P. 2005. Postpartum curettage: an audit of 200 cases. Aust N Z J Obstet Gynaecol 45:368–71. https://doi.org/10.1111/j.1479-828X.2005.00445.x; PMid:16171469

181. French L, Smaill FM. 2004. Antibiotic regimens for endometritis after delivery. Cochrane Database Syst Rev (4):CD001067. https://doi.org/10.1002/14651858.cd001067.pub2

182. Royal College of Obstetricians and Gynaecologists. Bacterial Sepsis following Pregnancy. Green-top Guideline 64b. London, RCOG. 2012.

183. Carlan SJ, Scott WT, Pollack R, Harris K. 1997. Appearance of the uterus by ultrasound immediately after placental delivery with pathologic correlation. J Clin Ultrasound 25:301–8. https://doi.org/10.1002/(SICI)1097-0096(199707)25:6<301::AID-JCU3>3.0.CO;2-G

184. de Vries JI, van der Linden RM, van der Linden HC. 2000. Predictive value of sonographic examination to visualize retained placenta directly after birth at 16 to 28 weeks. J Ultrasound Med 19:7–12. https://doi.org/10.7863/jum.2000.19.1.7; PMid:10625184

185. Edwards A, Ellwood DA. 2000. Ultrasonographic evaluation of the postpartum uterus. Ultrasound Obstet Gynecol 16:640–3. https://doi.org/10.1046/j.1469-0705.2000.00234.x; PMid:11169371

186. Sadan O, Golan A, Girtler O, Lurie S, Debby A, Sagiv R et al. 2004. Role of sonography in the diagnosis of retained products of conception. J Ultrasound Med 23:371–4. https://doi.org/10.7863/jum.2004.23.3.371; PMid:15055784

187. Mulic-Lutvica A, Axelsson O. 2006. Ultrasound finding of an echogenic mass in women with secondary postpartum hemorrhage is associated with retained placental tissue. Ultrasound Obstet Gynecol 28:312–9. https://doi.org/10.1002/uog.2849; PMid:16888708

188. Yi SW, Ahn JH. 2010. Secondary postpartum hemorrhage due to a pseudoaneurysm rupture at the fundal area of the uterus: a case treated with selective uterine arterial embolization. Fertil Steril 93:2048–9. https://doi.org/10.1016/j.fertnstert.2009.03.099; PMid:19423103

189. Arab TS, Dy J. 2011. Pseudoaneurysm of the vaginal artery as a cause of postpartum haemorrhage. J Obstet Gynaecol 31:185–6. https://doi.org/10.3109/01443615.2010.542514; PMid:21281042

190. Chitra TV, Panicker S. 2011. Pseudo-aneurysm of uterine artery: a rare cause of secondary postpartum hemorrhage. J Obstet Gynaecol India 61:641–4. https://doi.org/10.1007/s13224-011-0096-6; PMid:23204681 PMCid:PMC3307934

191. King PA, Duthie SJ, Dong ZG, Ma HK. 1989. Secondary postpartum haemorrhage. Aust N Z J Obstet Gynaecol 29:394–8. https://doi.org/10.1111/j.1479-828X.1989.tb01776.x; PMid:2631675

192. Jensen PA, Stromme WB. 1972. Amenorrhea secondary to puerperal curettage (Asherman’s syndrome). Am J Obstet Gynecol 113:150–7. https://doi.org/10.1016/0002-9378(72)90764-8

193. Sharma AM, Burbridge BE. 2011. Uterine artery pseudoaneurysm in the setting of delayed postpartum hemorrhage: successful treatment with emergency arterial embolization. Case Rep Radiol 2011:373482. https://doi.org/10.1155/2011/373482; PMid:22606544 PMCid:PMC3350022

194. Agrawal R, Legge F, Pollard K, Al-Inizi S. 2011. Massive secondary postpartum haemorrhage managed with insertion of a Bakri balloon catheter after surgical evacuation of the uterus. S Afr J Obstet Gynaecol 17:36–7.

195. Meri en AE, van de Ven J, Mol BW, Houterman S, Oei SG. 2010. Multidisciplinary team training in a simulation setting for acute obstetric emergencies: a systematic review. Obstet Gynecol 115:1021–31. https://doi.org/10.1097/AOG.0b013e3181d9f4cd; PMid:20410778

196. Royal College of Obstetricians and Gynaecologists. Improving Patient Safety: Risk Management for Maternity and Gynaecology. Clinical Governance Advice 2. London, RCOG. 2009.

197. Penney G, Brace V. 2007. Near miss audit in obstetrics. Curr Opin Obstet Gynecol 19:145–50. https://doi.org/10.1097/GCO.0b013e328014a860; PMid:17353683

198. Beck CT. 2004. Post-traumatic stress disorder due to childbirth: the aftermath. Nurs Res 53:216–24. https://doi.org/10.1097/00006199-200407000-00004; PMid:15266160

199. Dokmeta’s HS, Kilicli F, Korkmaz S, Yonem O. 2006. Characteristic features of 20 patients with Sheehan’s syndrome. Gynecol Endocrinol 22:279–83. https://doi.org/10.1080/09513590600630504; PMid:16785150